UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype

Cancer cell, 2016-04, Vol.29 (4), p.508-522

2016

Volltextzugriff (PDF)

Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons

The Journal of neuroscience, 2012-07, Vol.32 (27), p.9374-9382

2012

Volltextzugriff (PDF)

Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature

Clinical pharmacokinetics, 2016-03, Vol.55 (3), p.297-311

2016

Volltextzugriff (PDF)

Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma

Cancer cell, 2014-04, Vol.25 (4), p.516-529

2014

Volltextzugriff (PDF)

Reversal of Neuropathic Pain in Diabetes by Targeting Glycosylation of Cav3.2 T-Type Calcium Channels

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3828-3838

2013

Volltextzugriff (PDF)

Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3828-3838

2013

Volltextzugriff (PDF)

Abstract 2708: Development of an individualized 3D transport model of topotecan for a patient-derived orthotopic xenograft model of pediatric neuroblastoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2708-2708

2016

Volltextzugriff (PDF)

Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study

Drug metabolism and disposition, 2016-04, Vol.44 (4), p.591-594

2016

Volltextzugriff (PDF)

Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study

Cancer chemotherapy and pharmacology, 2015-05, Vol.75 (5), p.897-906

2015

Volltextzugriff (PDF)

Observational Evaluations of Mice during Cerebral Microdialysis for Pediatric Brain Tumor Research

Journal of the American Association for Laboratory Animal Science, 2015-05, Vol.54 (3), p.304-310

2015

Volltextzugriff (PDF)

Abstract A33: An individualized predictive 3D model of tumor response to topotecan for a patient-derived orthotopic xenograft model of pediatric neuroblastoma

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (2_Supplement), p.A33-A33

2017

Volltextzugriff (PDF)

Pharmacokinetic Properties of Anticancer Agents for the Treatment of CNS Tumors: Update of the Literature

Clinical pharmacokinetics, 2016-03, Vol.55 (3), p.297-311

2016

Volltextzugriff (PDF)

CNS PENETRATION OF THE CDK4/6 INHIBITOR RIBOCICLIB (LEE011) IN NON-TUMOR BEARING MICE AND MICE BEARING ORTHOTOPIC PEDIATRIC BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2016, Vol.18 (6)

2016

Volltextzugriff (PDF)

Abstract 4519: Development of a whole body physiologically-based pharmacokinetic (PBPK) model with individualized tumor compartment for topotecan (TPT) in mice bearing neuroblastoma (NB)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4519-4519

2015

Volltextzugriff (PDF)

Abstract 1496: Quantification of tumor blood perfusion of an orthotopic mouse model of neuroblastoma using nonlinear contrast-enhanced ultrasound imaging

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1496-1496

2015

Volltextzugriff (PDF)

Abstract 4645: Clofarabine, a potent anticancer compound with limited penetration in an orthotopic murine model of ependymoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4645-4645

2014

Volltextzugriff (PDF)

MB-32MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii104.1-iii104

2016

Volltextzugriff (PDF)

MB-19MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY

Neuro-oncology (Charlottesville, Va.), 2015-04, Vol.17 (Suppl 3), p.iii24-iii24

2015

Volltextzugriff (PDF)

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Neuro-oncology (Charlottesville, Va.), 2016, Vol.18 (3)

2016

Volltextzugriff (PDF)

Abstract 2749: Gemcitabine (GEM), a drug with clinical activity against pediatric solid tumors, demonstrates satisfactory CNS penetration in a preclinical murine medulloblastoma (MB) model

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2749-2749

2013

Volltextzugriff (PDF)

Reversal of Neuropathic Pain in Diabetes by Targeting Glycosylation of Ca^sub v^3.2 T-Type Calcium Channels

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3828

2013

Volltextzugriff (PDF)

Reversal of neuropathic pain in diabetes by targeting glycosylation of [Ca.sub.v]3.2 T-type calcium channels.(ORIGINAL ARTICLE)

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3828

2013

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype

Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons

Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature

Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma

Reversal of Neuropathic Pain in Diabetes by Targeting Glycosylation of Cav3.2 T-Type Calcium Channels

Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels

Abstract 2708: Development of an individualized 3D transport model of topotecan for a patient-derived orthotopic xenograft model of pediatric neuroblastoma

Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study

Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study

Observational Evaluations of Mice during Cerebral Microdialysis for Pediatric Brain Tumor Research

Abstract A33: An individualized predictive 3D model of tumor response to topotecan for a patient-derived orthotopic xenograft model of pediatric neuroblastoma

Pharmacokinetic Properties of Anticancer Agents for the Treatment of CNS Tumors: Update of the Literature

CNS PENETRATION OF THE CDK4/6 INHIBITOR RIBOCICLIB (LEE011) IN NON-TUMOR BEARING MICE AND MICE BEARING ORTHOTOPIC PEDIATRIC BRAIN TUMORS

Abstract 4519: Development of a whole body physiologically-based pharmacokinetic (PBPK) model with individualized tumor compartment for topotecan (TPT) in mice bearing neuroblastoma (NB)

Abstract 1496: Quantification of tumor blood perfusion of an orthotopic mouse model of neuroblastoma using nonlinear contrast-enhanced ultrasound imaging

Abstract 4645: Clofarabine, a potent anticancer compound with limited penetration in an orthotopic murine model of ependymoma

MB-32MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

MB-19MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Abstract 2749: Gemcitabine (GEM), a drug with clinical activity against pediatric solid tumors, demonstrates satisfactory CNS penetration in a preclinical murine medulloblastoma (MB) model

Reversal of Neuropathic Pain in Diabetes by Targeting Glycosylation of Ca^sub v^3.2 T-Type Calcium Channels

Reversal of neuropathic pain in diabetes by targeting glycosylation of [Ca.sub.v]3.2 T-type calcium channels.(ORIGINAL ARTICLE)

Suchergebnisse filtern